A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma
β Scribed by Giampietro Gasparini; Patrizia Boracchi; Pierantonio Bevilacqua; Maura Mezzetti; Franco Pozza; Noel Weidner
- Publisher
- Springer US
- Year
- 1994
- Tongue
- English
- Weight
- 892 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Bearing in mind the continuing controversy over the prognostic significance of epidermal growth factor receptor (EGF-r) expression, we investigated its clinical significance prospectively in 345 primary breast cancer patients. The prognostic significance of EGF-r expression, as measured by a radioli
To evaluate the clinical significance of the expression of epidermal growth factor receptor (EGFr) in oral squamous cell carcinoma (SCC), 100 formalin-fixed, paraffin-embedded cases of this tumour and ten samples of normal oral mucosa were immunostained with a monoclonal anti-EGFr antibody using an
Southern blot-hybridization analysis of 10 breast carcinoma cell lines demonstrated an amplification of the epidermal growth factor (EGF) receptor gene in the BTZO cell line. The gene was amplified 10to 14-fold when compared to the level seen in human placental DNA. Northern blot analysis indicated